©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 114743
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114743
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114743
Table 1 Baseline characteristics of the included patients, mean ± SD/n (%)
| Characteristic | Total (n = 148) |
| Age | 68.3 ± 8.29 |
| Gender (male/female) | 81 (55)/67 (45) |
| ASA | |
| 1 | 7 (4.7) |
| 2 | 62 (42.0) |
| 3 | 77 (52.0) |
| 4 | 2 (1.3) |
| BMI (kg/m2) | 26.2 ± 4.0 |
| Neoadjuvant chemotherapy | 2 (1.3) |
| Procedure | |
| PPPD | 137 (92.5) |
| Classical Whipple | 11 (7.5) |
| Type of malignancy | |
| Pancreatic | 94 (63.5) |
| Cholangiocarcinoma | 15 (10.1) |
| Duodenal | 9 (6.1) |
| Ampullary | 30 (20.3) |
| TNM stage | |
| I | 23 (15.6) |
| II | 116 (78.3) |
| III | 9 (6.1) |
| IV | 0 (0) |
| Poor | 81 (54.7) |
| Moderate | 59 (39.9) |
| Well | 5 (3.3) |
| Undifferentiated | 2 (1.4) |
| Unable to assess | 1 (0.7) |
| R status | |
| 0 | 68 (45.9) |
| 1 | 79 (53.4) |
| 2 | 1 (0.7) |
| Number of harvested lymph nodes | 20 ± 8.3 |
- Citation: Hajibandeh S, Hajibandeh S, Mckittrick H, Imrani U, Varghese A, Balasubramaniam R, Durkin D, Athwal TS. Psoas muscle variables and adjuvant chemotherapy-related and survival outcomes following pancreaticoduodenectomy for periampullary malignancy. World J Gastrointest Surg 2026; 18(2): 114743
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/114743.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.114743